Pyrrhic Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-01-2025
- Paid Up Capital ₹ 0.10 M
as on 11-01-2025
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -35.70%
(FY 2022)
- Profit -12.94%
(FY 2022)
- Ebitda -2.19%
(FY 2022)
- Net Worth 46.58%
(FY 2022)
- Total Assets 10.98%
(FY 2022)
About Pyrrhic Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Pyrrhic Pharma Private Limited India is Jayendrakumar Patel as CEO. Rohan Soni, Jayendrakumar Patel, and Ronak Patel serve as directors at the Company.
- CIN/LLPIN
U24230GJ2015PTC084029
- Company No.
084029
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pyrrhic Pharma Private Limited offer?
Pyrrhic Pharma Private Limited offers a wide range of products and services, including Surgical & Medical Consumables, Surgical Disposables, Surgical & ICU Equipments, CPAP Mask, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Ventilator, Towels, Napkins & Handkerchieves, Aprons, Oxygen Mask.
Who are the key members and board of directors at Pyrrhic Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayendrakumar Patel  | CEO | 17-Dec-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohan Soni | Director | 08-May-2023 | Current |
| Jayendrakumar Patel | Director and Ceo | 17-Dec-2018 | Current |
| Ronak Patel | Director | 08-May-2023 | Current |
Financial Performance of Pyrrhic Pharma.
Pyrrhic Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 35.7% decrease. The company also saw a substantial fall in profitability, with a 12.94% decrease in profit. The company's net worth Soared by an impressive increase of 46.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pyrrhic Pharma?
In 2019, Pyrrhic Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pyrrhic Pharma?
Unlock and access historical data on people associated with Pyrrhic Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pyrrhic Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pyrrhic Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
